List of health departments and ministries

BGI Genomics showcases high-throughput COVID testing air lab at Dubai World Expo

Retrieved on: 
Mercredi, janvier 12, 2022

DUBAI, UAE, Jan. 12, 2022 /PRNewswire/ --From January 11 to 13, a model of BGI Genomics' Huo-Yan Air Laboratory, was showcased at the China Pavilion of Dubai World Expo.

Key Points: 
  • DUBAI, UAE, Jan. 12, 2022 /PRNewswire/ --From January 11 to 13, a model of BGI Genomics' Huo-Yan Air Laboratory, was showcased at the China Pavilion of Dubai World Expo.
  • The smart Air Lab can be easily stored, transported, and seamlessly integrated with existing facilities when set up.
  • Chen Yue, Global Manager of Medicine at BGI Genomics, said, "This has provided BGI Genomics with a key opportunity go to the world stage.
  • Themed "Communicating Ideas, Creating the Future", this Expo is the first World Expo held in the Middle East.

BGI Genomics showcases high-throughput COVID testing air lab at Dubai World Expo

Retrieved on: 
Mercredi, janvier 12, 2022

DUBAI, UAE, Jan. 12, 2022 /PRNewswire/ --From January 11 to 13, a model of BGI Genomics' Huo-Yan Air Laboratory, was showcased at the China Pavilion of Dubai World Expo.

Key Points: 
  • DUBAI, UAE, Jan. 12, 2022 /PRNewswire/ --From January 11 to 13, a model of BGI Genomics' Huo-Yan Air Laboratory, was showcased at the China Pavilion of Dubai World Expo.
  • The smart Air Lab can be easily stored, transported, and seamlessly integrated with existing facilities when set up.
  • Chen Yue, Global Manager of Medicine at BGI Genomics, said, "This has provided BGI Genomics with a key opportunity go to the world stage.
  • Themed "Communicating Ideas, Creating the Future", this Expo is the first World Expo held in the Middle East.

Medtronic announces regulatory approval and launch in Japan of Micra AV Transcatheter Pacing System

Retrieved on: 
Lundi, janvier 10, 2022

The Micra TPS is the first-ever leadless pacemaker; its first version (the Micra VR) was approved in Japan in 2017 for patients who only require single-chamber pacing.

Key Points: 
  • The Micra TPS is the first-ever leadless pacemaker; its first version (the Micra VR) was approved in Japan in 2017 for patients who only require single-chamber pacing.
  • "The first Micra system transformed the concept of pacemakers by eliminating surgical pockets and leads, and Micra AV promises to deliver the benefits of leadless pacing to a larger number of patients because ventricular pacing can be performed synchronously with the atrium."
  • Identical in size and shape to the original Micra TPS, Micra AV has several additional algorithms which detect cardiac movement, allowing the device to adjust pacing in the ventricle to coordinate with the atrium, providing "AV synchronous" pacing therapy to patients with AV block.
  • The Micra AV approval is based on data from the MARVEL 2 (Micra Atrial Tracking Using A Ventricular accELerometer) study, which evaluated the safety and effectiveness of accelerometer-based atrial sensing algorithms.

New CBD Regulatory Framework Published by France’s Ministry of Health Opens New Commercial Opportunities for RAMM Pharma’s European Operations

Retrieved on: 
Mercredi, janvier 5, 2022

The French Health Ministry's ordinance, published on Friday 31 December, 2021 in the Journal Officiel, provides a new regulatory framework for the sale and trading of hemp extracts.

Key Points: 
  • The French Health Ministry's ordinance, published on Friday 31 December, 2021 in the Journal Officiel, provides a new regulatory framework for the sale and trading of hemp extracts.
  • "2022 begins with breakthrough news as it finally clarifies and opens the market for extracts and CBD in France.
  • Through its 100% ownership of Canapar Corp., RAMM is well positioned to become one of Europe's largest vertically integrated cannabis companies.
  • No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

BioHarvest Sciences Inc. 2021 CEO Letter to Shareholder Partners

Retrieved on: 
Jeudi, décembre 30, 2021

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - December 30, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) (OTC PINK: CNVCF) ("BioHarvest" or the "Company") is pleased to provide the following year-end shareholder partner letter from CEO Ilan Sobel.

Key Points: 
  • Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - December 30, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) (OTC PINK: CNVCF) ("BioHarvest" or the "Company") is pleased to provide the following year-end shareholder partner letter from CEO Ilan Sobel.
  • It is with great pleasure that I take this opportunity at the end of the year to summarize for our shareholder partners the major accomplishments of what has been an inspiring and transformative first full calendar year for me as CEO of BioHarvest Sciences.
  • While this highlight is only one of many from 2021, it represented a giant leap forward for BioHarvest Sciences.
  • Given the 2021 achievements record and the 2022 prospects listed below, we believe that BioHarvest presents a very attractive investment opportunity.

Oramed Subsidiary Oravax Medical Signs Cooperation and Purchase Agreement for an Initial Pre-Purchase of 10 Million Doses of Oral COVID-19 Vaccines with Tan Thanh Holdings to Commercialize in Southeast Asia

Retrieved on: 
Mercredi, décembre 29, 2021

The Agreement is for an initial pre-order of 10 million doses of oral COVID-19 vaccines from Oravax and is comprised of milestone payments.

Key Points: 
  • The Agreement is for an initial pre-order of 10 million doses of oral COVID-19 vaccines from Oravax and is comprised of milestone payments.
  • "This pre-purchase of our oral COVID-19 vaccine in development, represents a major milestone for Oravax Medical and another step forward in the implementation of our long-term strategy.
  • Oravax combines cutting-edge vaccine technology acquired from Premas Biotech and the proprietary POD oral delivery technology of Oramed Pharmaceuticals.
  • Established in 2006, with offices in the United States and Israel, Oramed has developed a novel Protein Oral Delivery (POD) technology.

Oramed Subsidiary Oravax Medical Signs Cooperation and Purchase Agreement for an Initial Pre-Purchase of 10 Million Doses of Oral COVID-19 Vaccines with Tan Thanh Holdings to Commercialize in Southeast Asia

Retrieved on: 
Mercredi, décembre 29, 2021

NEW YORK, Dec. 29, 2021 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, today announced that its subsidiary, Oravax Medical, has signed a Cooperation and Purchase Agreement with Vietnam-based Tan Thanh Holdings Investment Joint Stock Company to pre-purchase Oravax's oral COVID-19 vaccine, currently in development. The agreement grants Tan Thanh Holdings the right to sell Oravax's oral vaccine in development throughout the Association of Southeast Asian Nations (ASEAN) which includes Vietnam, Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, Singapore and Thailand. The Agreement is for an initial pre-order of 10 million doses of oral COVID-19 vaccines from Oravax and is comprised of milestone payments. The parties have agreed to negotiate follow-on orders potentially worth hundreds of millions of dollars.

Key Points: 
  • The Agreement is for an initial pre-order of 10 million doses of oral COVID-19 vaccines from Oravax and is comprised of milestone payments.
  • "This pre-purchase of our oral COVID-19 vaccine in development, represents a major milestone for Oravax Medical and another step forward in the implementation of our long-term strategy.
  • Oravax combines cutting-edge vaccine technology acquired from Premas Biotech and the proprietary POD oral delivery technology of Oramed Pharmaceuticals.
  • Established in 2006, with offices in the United States and Israel, Oramed has developed a novel Protein Oral Delivery (POD) technology.

Beyond2020 Improves Healthcare Access Services for 20,000 Rural Rwandans

Retrieved on: 
Lundi, décembre 27, 2021

ABU DHABI, UAE, Dec. 27, 2021 /PRNewswire/ -- Continuing to extend its support to rural communities in Africa, Beyond2020, the UAE-driven humanitarian initiative, has recently reached Rwanda offering critical access to healthcare services to a rural population of 20,000 people. The deployment aims to bring sustainable and affordable primary care to Rwanda's Nyaruguru and Rubavu districts, which lag behind the rest of the country in terms of health access and outcomes.

Key Points: 
  • ABU DHABI, UAE, Dec. 27, 2021 /PRNewswire/ -- Continuing to extend its support to rural communities in Africa, Beyond2020, the UAE-driven humanitarian initiative, has recently reached Rwanda offering critical access to healthcare services to a rural population of 20,000 people.
  • H.E Hazza Mohammed Al Qahtani, UAE Ambassador to Rwanda, said: "The UAE is proud to support critical access to healthcare in Rwanda through its humanitarian initiative, Beyond2020.
  • Expanding access to robust and resilient healthcare systems is of pivotal importance in managing the post-COVID-19 recovery, especially when it comes to overcoming service disruptions."
  • With poor access causing people to seek healthcare later and less often, preventable, and treatable illnesses can become life-threatening in remote rural settings.

Beyond2020 Improves Healthcare Access Services for 20,000 Rural Rwandans

Retrieved on: 
Lundi, décembre 27, 2021

ABU DHABI, UAE, Dec. 27, 2021 /PRNewswire/ -- Continuing to extend its support to rural communities in Africa, Beyond2020, the UAE-driven humanitarian initiative, has recently reached Rwanda offering critical access to healthcare services to a rural population of 20,000 people.

Key Points: 
  • ABU DHABI, UAE, Dec. 27, 2021 /PRNewswire/ -- Continuing to extend its support to rural communities in Africa, Beyond2020, the UAE-driven humanitarian initiative, has recently reached Rwanda offering critical access to healthcare services to a rural population of 20,000 people.
  • H.E Hazza Mohammed Al Qahtani, UAE Ambassador to Rwanda, said: "The UAE is proud to support critical access to healthcare in Rwanda through its humanitarian initiative, Beyond2020.
  • Expanding access to robust and resilient healthcare systems is of pivotal importance in managing the post-COVID-19 recovery, especially when it comes to overcoming service disruptions."
  • With poor access causing people to seek healthcare later and less often, preventable, and treatable illnesses can become life-threatening in remote rural settings.

EQS-News: Achiko AG looks back at pivotal year and reaffirms commitment to provide affordable and accurate Covid-19 testing solution

Retrieved on: 
Jeudi, décembre 23, 2021

"The threat is clearly more evident in low- and middle-income countries, where vaccine inequality and vaccine hesitancy is greater."

Key Points: 
  • "The threat is clearly more evident in low- and middle-income countries, where vaccine inequality and vaccine hesitancy is greater."
  • Results received during in-vitro trials in Spain and Indonesia indicated a greater sensitivity even at low viral loads.
  • The AptameX DNA aptamer tests can be rapidly chemically synthesised, are cost-effective and have wide potential across multiple disease diagnostics.
  • Leveraging AptameX and Teman Sehat, Achiko aims to deliver fast, accurate and affordable diagnostic testing for a range of pathogenic diseases and therapeutic indications in the rapidly evolving healthcare diagnostics field.